#stockmarket36 min ago
11 Stocks To Buy For Long Term: Morgan Stanley picks stocks for 2026 with up to 40% upside; Airtel, M&M, DLF on list
- Written by Ankit Kumar
Published: Zee Business| Updated: Zee Business
11 Stocks To Buy For Long Term: Morgan Stanley has identified Lenskart Solutions, Titan Company, Bharti Airtel, Mahindra & Mahindra (M&M), Divis Laboratories, Samvardhana Motherson International, Grasim Industries, Apollo Hospitals, Page Industries, Nykaa and DLF as its top long-term stock picks for 2026 across retail, jewellery, telecom, automobiles, pharmaceuticals, auto components, chemicals, healthcare, apparel, beauty and real estate. The brokerage has maintained Overweight ratings on all 11 stocks, citing strong earnings visibility, sector tailwinds and improving business momentum. Based on current market prices and target prices shared by Morgan Stanley, the potential upside across these stocks goes up to around 40 per cent, making them attractive options for long-term investors seeking steady growth.
Representational image: Unsplash
(Disclaimer: The views/suggestions/recommendations expressed in this article are solely those of investment experts. The platform does not advise investors to buy or sell stocks. Please consult your financial adviser before making investment decisions.)
1/11
Lenskart Solutions Share Price Target | Upside 15%
1/11Lenskart Solutions is rated Overweight, with the stock trading at Rs 489.40 and a revised target price of Rs 561, implying an upside of around 14.6 per cent. Morgan Stanley upgraded the stock from Equalweight, citing strong India growth and improving margins.
2/11
Titan Company Share Price Target | Upside 7%
2/11Titan Company carries an Overweight rating, trading at Rs 4,236.40 with a target price of Rs 4,529, indicating an upside of about 6.9 per cent. Morgan Stanley highlighted strong jewellery revenue growth driven by festive demand and exchange programmes.
3/11
Bharti Airtel Share Price Target | Upside 24%
3/11Bharti Airtel is rated Overweight, with the stock trading at Rs 1,977.80 and a target price of Rs 2,450, translating into an upside of around 23.9 per cent. Morgan Stanley remains positive due to strong cash flow generation and improving ARPU trends.
4/11
Mahindra & Mahindra Share Price Target | Upside 28%
4/11Mahindra & Mahindra carries an Overweight rating, trading at Rs 3,412.80 with a target price of Rs 4,358, suggesting an upside of about 27.7 per cent. Morgan Stanley expects growth moderation in FY27 followed by recovery in FY28.
5/11
Divis Laboratories Share Price Target | Upside 27%
5/11Divis Laboratories is rated Overweight, trading at Rs 6,291 with a target price of Rs 7,989, implying an upside of around 27.0 per cent. Morgan Stanley raised the target following improving earnings visibility.
6/11
Samvardhana Motherson Share Price Target | Upside 11%
6/11Samvardhana Motherson carries an Overweight rating, trading at Rs 129.42 with a target price of Rs 144, indicating an upside of about 11.3 per cent. Morgan Stanley expects growth from acquisitions and aerospace business expansion.
7/11
Grasim Industries Share Price Target | Upside 30%
7/11Grasim Industries is rated Overweight, trading at Rs 2,832.80 with a target price of Rs 3,690, translating into an upside of around 30.3 per cent. Morgan Stanley remains positive on paints expansion and strong cellulose performance.
8/11
Apollo Hospitals Share Price Target | Upside 16%
8/11Apollo Hospitals carries an Overweight rating, trading at Rs 7,615.50 with a target price of Rs 8,813, suggesting an upside of about 15.7 per cent. Morgan Stanley highlighted steady revenue growth and improving margins.
9/11
Page Industries Share Price Target | Upside 40%
9/11Page Industries is rated Overweight, trading at Rs 32,740 with a target price of Rs 45,930, implying an upside of around 40.3 per cent. Morgan Stanley remains constructive despite trimming the target.
10/11
Nykaa Share Price Target | Upside 8%
10/11Nykaa carries an Overweight rating, trading at Rs 265.58 with a target price of Rs 286, indicating an upside of about 7.7 per cent. Morgan Stanley highlighted consistent growth and improving profitability.
11/11
DLF Share Price Target | Upside 19%
11/11DLF is rated Overweight, trading at Rs 629.30 with a target price of Rs 750, translating into an upside of around 19.2 per cent. Morgan Stanley remains positive on long-term real estate demand.
- 1
- 2
- 3
- 4
- 5
- 6